Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia.
Saved in:
| Title: | Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia. |
|---|---|
| Authors: | McQuilten ZK; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Monash Health, Melbourne, Australia., Busija L; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia., Seymour JF; Department of Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Stanworth S; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Clinical Department, NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, and NIHR Oxford Biomedical Research Centre, Oxford, UK., Wood EM; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Monash Health, Melbourne, Australia., Kenealy M; Cabrini Health, Melbourne, Australia.; Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Australia., Weinkove R; Wellington Blood & Cancer Centre, Capital & Coast District Health Board, Wellington, New Zealand.; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Pathology and Molecular Medicine, University of Otago Wellington, Wellington, New Zealand. |
| Corporate Authors: | Australasian Leukaemia and Lymphoma Group (ALLG) |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2022 Mar; Vol. 63 (3), pp. 676-683. Date of Electronic Publication: 2021 Dec 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2021.2012664 |
